Eli Lilly Acquiring Cancer Therapy Developer For $1.4 Billion—A Nearly 90% Premium

American pharmaceutical company Eli Lilly plans to acquire cancer therapy firm Point Biopharma Global, the companies announced Tuesday, an expansion that comes as manu...

Related Posts

Apple Loop: Faster iPhone 17 Leaks, Disappointing iPhon...

risingforbes Sep 27, 2024  0  1

From Promo Codes To Cashback: Ensuring Safe Shopping Fo...

risingforbes Apr 12, 2024  0  1

EV Sales Losing Juice? Release The Kraken, Er, Cybertruck

risingforbes Oct 29, 2023  0  3

Comments

Name

Email

Comment

Post Comment